“FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON: Pidotimod: Revisiting a Classic Immunomodulator”. 2025. Mediterranean Journal of Hematology and Infectious Diseases 17 (1): e2025057. https://doi.org/10.4084/MJHID.2025.057.